Enhance Skin Products Inc

Certification of termination of registration of a class of securities (Section 12(g))

8.01

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

2.01,3.02

4.01,9.01

Definitive information statement

No description available

1.01,8.01,9.01

1.01,9.01

1.01,9.01

1.01,9.01

1.01,9.01

General form for quarterly reports under Section 13 or 15(d)

1.01,9.01

1.01,9.01

1.01,9.01

1.01,9.01

Annual report pursuant to Section 13 or 15(d)

1.01,2.03,9.01

1.01,2.03,3.02,9.01

General form for quarterly reports under Section 13 or 15(d)

1.01,2.03,3.02,9.01

Unregistered Sales of Equity Securities

General form for quarterly reports under Section 13 or 15(d) (amendment)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

Entry into a Material Definitive Agreement

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

1.01,2.03,3.02,9.01

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Definitive information statement

No description available

1.01,2.03,3.02,9.01

General form for quarterly reports under Section 13 or 15(d) (amendment)

06b

8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Annual report pursuant to Section 13 or 15(d) (amendment)

Letter from the SEC

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

06

Definitive information statement

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Definitive information statement

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Correspondence with the SEC

Letter from the SEC

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

No description available

Notice of Effectiveness

No description available

Asculai Samuel

Botnevik Frode

Puseljic Drasko

Nicholson Donald

Botnevik Frode

Asculai Samuel

Asculai Samuel

Nicholson Donald

Biostrategies Consulting Group Inc

Asculai Samuel

Puseljic Drasko

Nicholson Donald

Noon Zenas B.

Botnevik Frode

Nicholson Donald

Hovey Christopher